Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/f1224815-cddd-4bfb-8dc3-fe2858461148/
LGND
Ligand Pharmaceuticals IncorporatedSnapshot 2026-07-19 · 0.6w · Fresh
Strategy Eligibility
4 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 15%
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 98%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.74
⚡
Risk-Adj Momentum
RAM 2.87
V
Value Analysis
Cheapness relative to fundamentals
2.0%ile
P/E
39.6×
P/S
22.2×
P/B
6.1×
E/P
0.0293
FCF Yield
0.019
EBITDA/EV
0.035
SH Yield
0.002
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
97.00000000
/100 — 1=cheapest
VC2 (Trending Value)
97.00000000
/100
VC3 (Buyback)
97.00000000
/100
P/E of 39.6x is premium-priced — the market is paying up for expected growth. VC2 score of 97.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
85.0%ile
ROE
0.154
ROA
0.100
Net Margin
0.559
Op Margin
0.684
GPA
0.177
D/E
0.54
Current
21.28
F-Score
5/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.512
Stability
21.137
lower=better
Accruals
0.020
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
94.0%ile
6M Return
57.2%
12M Return
118.1%
12-1 Mom
97.6%
Risk-Adj
2.87
Vol 252d
34.0%
Vol 60d
78.5%
↑ Expanding
Max DD 12M
-11.0%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 98% is very strong — a clear uptrend. Risk-adjusted momentum of 2.87 is excellent — strong returns relative to volatility. Near-term vol (78%) is expanding vs long-term (34%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.44
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
1.4%
Sector Quality %ile
86.6%
P/E z-score
0.22
P/B z-score
-0.03
Sector Avg OS
64.1%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (85th) and momentum (94th) but expensive (2th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (85th) but expensive (2th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (78%) significantly exceeds 252-day (34%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
18.2% avg (7 factors)
Quality
B
71.0% avg (8 factors)
Momentum
A
99.2% avg (4 factors)
Risk
C
59.9% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends7 snapshots
Factor Persistence7 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.440 | —0 | — | |
| Value %ile | 0.020 | —7 | — | |
| Quality %ile | 0.850 | —7 | — | |
| Momentum %ile | 0.940 | —7 | — | |
| F-Score | 5.000 | —0 | — | |
| Confidence | 0.910 | —7 | — | |
| Volatility | 0.340 | —0 | — |
Value Lens2021-07-20 → 2026-07-19
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
39.60
Earnings Yield (E/P)
0.0293
Price / Sales
22.15
Price / Book
6.10
Price / Cash Flow
49.26
FCF Yield
1.9%
EBITDA / EV
3.5%
Sales Yield (1/P·S)
0.0428
Shareholder Yield
Div + net buyback / mktcap
0.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.4%
Return on Assets
10.0%
Net Margin
55.9%
Operating Margin
68.4%
Gross Profit / Assets
Novy-Marx GPA
17.7%
Debt / Equity
0.54
Current Ratio
21.28
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.020
External Financing
Net issuance — lower=better
0.010
MomentumPrice trend strength over different horizons
6M Return
57.2%
12M Return
118.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
97.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
2.87
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
51.2%
Earnings Stability (CV)
Lower = more stable
21.137
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
5
Buyback Yield
0.2%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
97
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
97
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
97
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity